DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Norketamine is an investigational drug.
There have been 8 clinical trials for Norketamine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2016.
The most common disease conditions in clinical trials are Acute Pain, Pain, Postoperative, and Chronic Pain. The leading clinical trial sponsors are Tel-Aviv Sourasky Medical Center, University of Texas Southwestern Medical Center, and Columbia University.
There are twelve US patents protecting this investigational drug and forty-nine international patents.
Recent Clinical Trials for Norketamine
|The Role of HNKs in the Antidepressant Effect of Ketamine||Columbia University||Phase 1|
|Acute Pain Management in Patients on Opioid Replacement Therapy||University of California, San Francisco||Phase 1|
|Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia||Tampere University Hospital||Phase 4|
Top disease conditions for Norketamine
Top clinical trial sponsors for Norketamine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Norketamine||Start Trial||Ketamine derivatives||Auckland Uniservices Limited (Auckland, NZ)||Start Trial|
|Norketamine||Start Trial||Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods||Amorsa Therapeutics, Inc. (Littleton, MA)||Start Trial|
|Norketamine||Start Trial||Assay for methoxetamine||Randox Laboratories Ltd. (GB)||Start Trial|
|Norketamine||Start Trial||Oral dosage forms of ketamine||Develco Pharma Schweiz AG (Pratteln, CH)||Start Trial|
|Norketamine||Start Trial||Ketamine analogues for treatment of thrombocytopenia||Genentech, Inc. (South San Francisco, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Norketamine||Eurasian Patent Organization||201590697||2032-10-08||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|